Biocon arm Biocon Pharma receives approval for Tacrolimus capsules in China

Share it

Shares of Biocon Ltd ended at ₹372.95, up by ₹4.15, or 1.13% on the BSE.

Leave a Comment

Your email address will not be published. Required fields are marked *